%0 Generic
%T A phase I trial of the trifunctional anti Her2 × anti CD3 antibody ertumaxomab in patients with advanced solid tumors
%A Hänse, Nicole
%A Marmé, Frederik
%I BioMed Central; Springer
%D 2016
%X Aus: BMC Cancer, 16 (2016), Nr. 420. pp. 1-10. ISSN 1471-2407
%C BioMed Central; Springer
%C London; Berlin; Heidelberg
%U http://slubdd.de/katalog?TN_libero_mab2
Download citation